Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 3,000 shares of the technology company’s stock, valued at approximately $1,094,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of Celestica by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 4,811,695 shares of the technology company’s stock valued at $1,423,333,000 after purchasing an additional 73,022 shares during the last quarter. JPMorgan Chase & Co. increased its position in Celestica by 24.8% during the fourth quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company’s stock worth $1,187,650,000 after buying an additional 798,782 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in Celestica by 5,806,149.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company’s stock worth $1,081,323,000 after buying an additional 3,657,874 shares during the period. Franklin Resources Inc. lifted its stake in Celestica by 18.6% in the fourth quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company’s stock valued at $673,471,000 after buying an additional 356,797 shares during the last quarter. Finally, Cibc World Market Inc. boosted its holdings in shares of Celestica by 30.6% in the fourth quarter. Cibc World Market Inc. now owns 2,265,680 shares of the technology company’s stock valued at $670,279,000 after acquiring an additional 530,535 shares during the period. Institutional investors and hedge funds own 67.38% of the company’s stock.
Celestica Trading Down 0.2%
NYSE:CLS opened at $296.03 on Monday. Celestica, Inc. has a 12-month low of $179.01 and a 12-month high of $474.02. The company has a current ratio of 1.23, a quick ratio of 0.68 and a debt-to-equity ratio of 0.32. The stock’s 50 day simple moving average is $341.15 and its 200-day simple moving average is $335.51. The firm has a market cap of $34.04 billion, a P/E ratio of 30.77 and a beta of 2.06.
Insider Buying and Selling
In other Celestica news, CFO Mandeep Chawla sold 16,117 shares of the business’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $369.32, for a total transaction of $5,952,330.44. Following the sale, the chief financial officer directly owned 65,444 shares in the company, valued at approximately $24,169,778.08. The trade was a 19.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Robert Mionis sold 23,496 shares of the company’s stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $362.39, for a total transaction of $8,514,715.44. Following the transaction, the chief executive officer directly owned 23,396 shares in the company, valued at approximately $8,478,476.44. This trade represents a 50.11% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 356,553 shares of company stock worth $135,238,444 in the last ninety days. 1.10% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on CLS shares. Barclays lowered their target price on shares of Celestica from $430.00 to $406.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. UBS Group raised shares of Celestica from a “neutral” rating to a “buy” rating and set a $430.00 price objective on the stock in a research report on Monday. Stifel Nicolaus set a $500.00 price objective on shares of Celestica in a research note on Tuesday, July 28th. Wolfe Research lifted their price objective on shares of Celestica from $425.00 to $475.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. Finally, Scotiabank started coverage on shares of Celestica in a report on Tuesday, August 11th. They issued a “sector outperform” rating and a $500.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $439.81.
Get Our Latest Stock Report on CLS
Celestica Company Profile
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Recommended Stories
- Five stocks we like better than Celestica
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
